Enanta Pharmaceuticals Inc ENTA.O :
* ENANTA PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR ITS
FISCAL
FIRST QUARTER ENDED DECEMBER 31, 2022 WITH WEBCAST AND
CONFERENCE CALL TODAY AT 4:30 P.M. ET
* ENANTA PHARMACEUTICALS INC - REVENUE FOR QUARTER WAS $23.6
MILLION
* ENANTA PHARMACEUTICALS INC - CASH, CASH EQUIVALENTS AND
SHORT-TERM AND LONG-TERM MARKETABLE SECURITIES TOTALED $241.4
MILLION AT DECEMBER 31, 2022
* ENANTA PHARMACEUTICALS INC - NET LOSS FOR THREE MONTHS
ENDED
DECEMBER 31, 2022 WAS $29.0 MILLION, OR A LOSS OF $1.39 PER
DILUTED COMMON SHARE
Source text for Eikon: ID:nBwVjpTta
Further company coverage: ENTA.O